Diabetes Clinical Trials in Tennessee

Showing 461-480 of 532 trials

Effect of Platelet Concentrate in Treatment of Diabetic Ulcers

NCT00215735

Autologous platelet concentrate will enhance the rate of healing of chronic diabetic wounds

Harvest TechnologiesStarted Jun 2004

Fayetteville, Alaska, United States • Orlando, Florida, United States • St. Petersburg, Florida, United States +6 more locations

COMPLETED71 miles

Screening for Early Evidence of Diabetes

NCT00614783

This is a pivotal study to determine the accuracy of a new device (SCOUT) in screening persons for pre-diabetes or diabetes. SCOUT will be compared to the standard screening test (Fasting Plasma Glucose), using the Oral Glucose Tolerance Test as the reference standard. SCOUT uses a rapid, noninvasive, light-based technology to measure the concentration of chemicals in the skin called advanced glycation endproducts (AGEs). Several studies have demonstrated that AGEs accumulate in skin faster in individuals with poor control of blood sugar. Persons will be eligible for the study if they are 'at risk' for diabetes based on their age and other risk factors as defined by the American Diabetes Association.

Diabetes Mellitus, Type 2

VeraLight, Inc.3,478 participantsStarted May 2007

Huntsville, Alabama, United States • San Diego, California, United States • San Diego, California, United States +12 more locations

Effect of Platelet Concentrate in Treatment of Diabetic Ulcers

Screening for Early Evidence of Diabetes

Diabetes Trials in Other Cities

Study of Alogliptin Combined With Sulfonylurea in Subjects With Type 2 Diabetes Mellitus.

A 12 Week Study in Patients With Type 2 Diabetes Mellitus (T2DM)

A Trial to Evaluate BMS-298585 as Monotherapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control

Follow-Up Study for Exubera

Study to Compare Pioglitazone and Rosiglitazone in Subjects With Type 2 Diabetes Mellitus and Dyslipidemia

Evaluation of Low Source of Signal in SCOUT DS

Study of VI-0521 Compared to Placebo in Treatment of Diabetes and Obesity in Adults With Obesity-Related Co-Morbid Conditions

A Comparison Of Study Drug Blood Levels After One Dose Of GSK189075 In Subjects With Normal And Reduced Kidney Function

Safety and Efficacy of Once-daily Oral Administrations of TZP-102 for Gastroparesis in Patients With Diabetes Mellitus

Testing the Developmental Origins Hypothesis

Effect Of Paricalcitol (Zemplar) On Endothelial Function And Inflammation In Type 2 Diabetes And Chronic Kidney Disease

Multicenter Worksite Nutrition Study

Evaluate the Safety and Tolerability of INCB019602 When Administered With Metformin in Patients With Type 2 Diabetes

Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy

Study of Metamucil on Blood Glucose and HbA1c in Type II NIDDM Subjects

Mechanisms of Glucose Lowering Effect of Colesevelam HCl

Evaluate Efficacy, Safety and Tolerability of AZD1656 as Add-on Treatment to Metformin in Type 2 Diabetes Mellitus (TD2M) Patients

Lantus Versus NPH: Comparison in Insulin Naive People Not Adequately Controlled With at Least One Oral Anti Diabetics (OAD) Treatment

Other Conditions in Tennessee